Showing results (21-30 of 11,000) with videos related to
Sort By:
Pageof 1,100
Molecular Biosystems|September 5, 2006
Genomics and the second golden era of cancer drug developmentPaul WorkmanCurrent Cancer Drug Targets|October 8, 2003
Overview: translating Hsp90 biology into Hsp90 drugsPaul WorkmanChemico-Biological Interactions|January 1, 1978
Inhibition of human prostatic tumour acid phosphatase by N,N-p-di-2-chloroethylaminophenol, N,N-p-di-2-chloroethylaminophenyl phosphate and other difunctional nitrogen mustardsP WorkmanCurrent Opinion in Pharmacology|November 17, 2001
Scoring a bull's-eye against cancer genome targetsP WorkmanCancer Detection and Prevention|January 1, 2003
Pharmacogenomics in cancer drug discovery and development: inhibitors of the Hsp90 molecular chaperonePaul WorkmanCancer Chemotherapy and Pharmacology|January 1, 1980
Dose-dependence and related studies on the pharmacokinetics of misonidazole and desmethylmisonidazole in miceP WorkmanNursing Standard (Royal College of Nursing (Great Britain) : 1987)|January 15, 2017
Relieving staff stress would boost safety and efficiencyGilly WorkmanTrends in Molecular Medicine|April 27, 2004
Altered states: selectively drugging the Hsp90 cancer chaperonePaul WorkmanJournal of Chemotherapy (Florence, Italy)|February 4, 2005
Drug discovery strategies: technologies to accelerate translation from target to drugP WorkmanCurrent Opinion in Investigational Drugs (London, England : 2000)|February 7, 2004
Strategies for treating cancers caused by multiple genome abnormalities: from concepts to cures?Paul WorkmanPageof 1,100